Molina Healthcare cuts FY25 adjusted EPS guidance to $21.50-$22.50; Q2 preliminary $5.50

MOLINA HEALTHCARE, INC.

2025-Q2 EPS reported $10.19 vs consensus $5.85 ▲ beat (+74.3%)

Q2 2025 preliminary adjusted EPS ~$5.50, modestly below prior expectations due to medical cost pressures across all lines of business.
FY 2025 adjusted EPS guidance reduced to $21.50-$22.50 per share; consolidated pre-tax margin just under 4% (low-end of long-term range).
CEO cites temporary dislocation between premium rates and accelerating medical cost trend; long-term outlook unchanged.
Company expects medical cost pressures to continue into H2 2025.
Full Q2 results to be reported on July 23, 2025, with conference call on July 24, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.